CN111413451A - Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography - Google Patents
Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography Download PDFInfo
- Publication number
- CN111413451A CN111413451A CN202010260417.7A CN202010260417A CN111413451A CN 111413451 A CN111413451 A CN 111413451A CN 202010260417 A CN202010260417 A CN 202010260417A CN 111413451 A CN111413451 A CN 111413451A
- Authority
- CN
- China
- Prior art keywords
- cyanoacetamide
- high performance
- performance liquid
- solution
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/89—Inverse chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
The invention relates to the technical field of detection and analysis, in particular to a method for detecting cyanoacetamide by using a reversed-phase high performance liquid chromatography, which adopts the following chromatographic conditions that a chromatographic column is an Agilent ZORBAX Eclipse XDB-CN liquid chromatographic column (4.6mm × 250mm, 5um), a mobile phase is acetonitrile-ammonium formate volatile buffer solution, the flow rate is 0.5m L/min, the detection wavelength is 200nm, the column temperature is 40 ℃, the sample injection amount is 5u L, and a diode array detector is adopted as the detector.
Description
Technical Field
The invention relates to the technical field of detection and analysis, in particular to a method for detecting cyanoacetamide by using a reversed-phase high performance liquid chromatography.
Background
Cyanoacetamide is a commonly used organic synthetic raw material for the synthesis of malononitrile, electroplating solution and pesticides triamterene and aminopterin. It is used as an important synthesis intermediate, and malononitrile can be generated by dehydration; brominating to obtain 2, 2-dibromo-2-cyanoacetamide; cyclizing the compound with ethyl trifluoroacetoacetate to obtain a substituted pyridine compound, and synthesizing to obtain the insecticide flonicamid; also, cyanoacetamide is one of the important raw materials for the fungicide fludioxonil. The structural formula is as follows:
the cyanoacetamide is used as an important raw material in the chemical industry, the residue of the cyanoacetamide is generally detected by a quantitative method at present, and the like adopts normal-phase high performance liquid chromatography, an XDB-CN column is used, and a mixed solvent of ethanol and normal hexane is used as a mobile phase to separate and quantitatively analyze a cyanoacetamide sample. Patent CN103926333A provides a high performance liquid chromatography detection method of cyanoacetamide, the chromatographic conditions adopted by the method are: a chromatographic column: Polar-Silica, particle size 5 μm, length 250mm, diameter 4.6mm, pore size
The detection is carried out by adopting a high performance liquid phase reversed phase ODS column, C18 or C8, but the polarity of the cyanoacetamide is higher, the reversed phase high performance liquid chromatography which has good separation degree and high column stability is urgently needed.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides the method for detecting the cyanoacetamide by the reversed-phase high performance liquid chromatography, which has the advantages of good separation degree, high accuracy and good column stability.
The invention provides a method for detecting cyanoacetamide by reversed-phase high-performance chromatography, which adopts the following chromatographic conditions:
chromatographic column Agilent ZORBAX Eclipse XDB-CN liquid chromatographic column (4.6mm × 250mm, 5 um);
mobile phase: acetonitrile-ammonium formate volatile buffer solution;
the flow rate is 0.5m L/min;
detection wavelength: 200 nm;
column temperature: 40 ℃;
the sample injection amount is 5u L;
the detector is a diode array detector.
The volume ratio of acetonitrile to the volatile buffer solution of ammonium formate in the mobile phase is 7-15: 90. The time to peak is shortened with increasing acetonitrile ratio.
Formamide can volatilize the pH value of the buffer solution to 6.5-7.5. Maintaining this pH prevents deterioration of the cyanoacetamide and is better suited for chromatographic performance.
The mobile phase can also be acetonitrile-methanol-ammonium formate volatile buffer solution.
The volatile buffer solution of ammonium formate and the organic phase in the mobile phase do not need to be premixed (namely, the organic phase and the aqueous phase are mixed in proportion in advance and then used), and the organic phase and the volatile buffer solution of ammonium formate are directly and separately fed by a double pump; if the organic phase is a mixed phase of methanol and acetonitrile, the organic phase can be premixed and then the organic phase and the volatile buffer solution of ammonium formate can be pumped in by a double pump.
The detection wavelength is 200nm, the area of the cyanoacetamide peak is in a descending trend along with the red shift of the wavelength, the wavelength is in a blue shift, and the baseline is deteriorated.
The chromatographic conditions are preferably that the volume ratio of acetonitrile to ammonium formate buffer solution in the mobile phase is 10:90, the flow rate is 0.5m L/min, the detection wavelength is 200nm, the column temperature is 40 ℃, and the injection volume is 5u L.
A method for detecting cyanoacetamide by reversed phase high performance chromatography comprises the following steps:
(1) preparation of standard sample solution
Accurately weighing a standard sample containing 0.05g (accurate to 0.0002g) of cyanoacetamide, placing the standard sample in a volumetric flask with the volume of 100m L, adding acetonitrile solution with the volume of 90m L, dissolving the standard sample by ultrasonic oscillation, cooling the solution to room temperature, using acetonitrile to scale, and shaking the solution uniformly for later use;
(2) preparation of sample solution
Accurately weighing a sample containing 0.05g (accurate to 0.0002g) of cyanoacetamide, placing the sample in a volumetric flask with the volume of 100m L, adding 90m L of acetonitrile solution, dissolving the sample by ultrasonic oscillation, cooling the solution to room temperature, using acetonitrile to scale, and shaking the solution uniformly for later use;
(3) measurement of
Under the operating conditions, after the baseline of the instrument is stable, continuously injecting a plurality of needles of standard sample solution until the response value of the cyanoacetamide of two adjacent needles relatively changes by less than 0.5 percent, and then measuring according to the sequence of the standard sample solution, the sample solution and the standard sample solution;
(4) computing
And respectively averaging the areas of the cyanoacetamide peaks of the two-needle sample solution and the two-needle standard sample solution before and after the sample.
Agilent ZORBAX Eclipse XDB chromatography columns (C18, C8, phenyl and cyano) provided four bound stationary phases for optimization of process development. These columns can provide good peak profiles over a wide pH range (pH 2-9), eclipse xdb columns can be used for process development under low pH (2-3) conditions, and the same columns can also be used for process development over a medium pH range (6-8) where residual silanol activity is greater and interactions are more likely to occur, causing peak tailing. To overcome these interactions, Eclipse XDB columns were ultra-tightly bonded and double-capped by proprietary processes to cover as many reactive silanol groups as possible. The final basic compound has an excellent peak shape in the pH range of 2-9. High speed, high separation degree, analysis and preparation amplification separation are realized.
The beneficial effect of the invention is that,
(1) acetonitrile-ammonium formate volatile buffer solution is used as a mobile phase, and the pH value of formamide volatile buffer solution is 6.5-7.5, so that the damage to a chromatographic column can be effectively avoided, and the interference of the absorption of the mobile phase or a solvent under short wave on sample detection can be effectively avoided;
(2) the effective retention of the cyanoacetamide can be realized, so that the interference of solvent peaks, inverted peaks and impurity peaks is avoided, and the rapid and accurate detection can be realized;
(3) the effective separation of the cyanoacetamide and the impurities within 6.5min can be realized;
(4) the selected chromatographic column has good stability, the preparation of the mobile phase is simple, and the detection cost is low;
(5) the method can better realize the quality control of the cyanoacetamide, improves the accuracy of analysis, and has high accuracy, and good detection linearity and range, recovery rate, precision and other tests.
Drawings
In order to more clearly illustrate the embodiments or technical solutions in the prior art of the present invention, the drawings used in the description of the embodiments or prior art will be briefly described below, and it is obvious for those skilled in the art that other drawings can be obtained based on these drawings without creative efforts.
FIG. 1 is a graph of a cyanoacetamide standard curve;
FIG. 2 is a chromatogram of a sample from example 1.
Detailed Description
In order to make those skilled in the art better understand the technical solution of the present invention, the technical solution in the embodiment of the present invention will be clearly and completely described below with reference to the drawings in the embodiment of the present invention, and it is obvious that the described embodiment is only a part of the embodiment of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A method for detecting cyanoacetamide by reversed-phase high-performance liquid chromatography comprises the following steps of carrying out Agilent ZORBAX Eclipse XDB-CN liquid chromatography column (4.6mm × 250mm, 5um) on a chromatographic column, carrying out acetonitrile-ammonium formate volatile buffer solution on a mobile phase, carrying out flow rate of 0.5m L/min, carrying out detection wavelength of 200nm, carrying out column temperature of 40 ℃, carrying out sample introduction of 5u L, and using a diode array detector as the detector.
The specific operation steps are as follows:
(1) preparation of standard sample solution
Accurately weighing a standard sample containing 0.05g (accurate to 0.0002g) of cyanoacetamide, placing the standard sample in a 100m L volumetric flask, adding 90m L of acetonitrile solution, dissolving by ultrasonic oscillation, cooling to room temperature, adding acetonitrile to the scale, and shaking uniformly for later use.
(2) Preparation of sample solution
Accurately weighing a sample containing 0.05g (accurate to 0.0002g) of cyanoacetamide, placing the sample in a 100m L volumetric flask, adding 90m L of acetonitrile solution, dissolving by ultrasonic oscillation, cooling to room temperature, adding acetonitrile to the scale, and shaking uniformly for later use.
(3) Measurement of
Under the operating conditions, after the baseline of the instrument is stable, a plurality of needles of standard sample solution are continuously injected until the response value of the cyanoacetamide of two adjacent needles relatively changes by less than 0.5%, and then the standard sample solution, the sample solution and the standard sample solution are sequentially measured. The sample chromatogram is shown in FIG. 2.
(4) Computing
And respectively averaging the areas of the cyanoacetamide peaks of the two-needle sample solution and the two-needle standard sample solution before and after the sample. The mass fraction of the cyanoacetamide is X1(%), calculated as follows:
in the formula:
A1-average value of area of cyanoacetamide in the standard solution;
A2-average value of area of cyanoacetamide in the sample solution;
m1-mass of cyanoacetamide standard, g;
m2-mass of sample, g;
mass fraction of p-cyanoacetamide,%.
The test data are shown in the following table 1:
TABLE 1 relevant test data
The mass fraction of the sample is calculated to be 98.08%.
(5) Authentication
① accuracy analysis of the samples, see table 1.
TABLE 1 accuracy test results of samples
② analysis of recovery experimental data with standard:
TABLE 2 results of sample spiking recovery test data
Although the present invention has been described in detail by referring to the drawings in connection with the preferred embodiments, the present invention is not limited thereto. Various equivalent modifications or substitutions can be made on the embodiments of the present invention by those skilled in the art without departing from the spirit and scope of the present invention, and these modifications or substitutions are within the scope of the present invention/any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (6)
1. A method for detecting cyanoacetamide by reversed phase high performance liquid chromatography is characterized by adopting the following chromatographic conditions:
chromatographic column Agilent ZORBAX Eclipse XDB-CN liquid chromatographic column (4.6mm × 250mm, 5 um);
mobile phase: acetonitrile-ammonium formate volatile buffer solution;
the flow rate is 0.5m L/min;
detection wavelength: 200 nm;
column temperature: 40 ℃;
the sample injection amount is 5u L;
the detector is a diode array detector.
2. The method for detecting cyanoacetamide by reverse-phase high performance liquid chromatography as claimed in claim 1, wherein the volume ratio of acetonitrile to volatile buffer solution of ammonium formate in the mobile phase is 7-15: 90.
3. The method for detecting cyanoacetamide according to claim 1, wherein the formamide-volatilizable buffer solution has a pH of 6.5-7.5.
4. The method for detecting cyanoacetamide by reverse-phase high performance liquid chromatography as claimed in claim 1, wherein the chromatographic conditions are that the volume ratio of acetonitrile to ammonium formate buffer solution in the mobile phase is 10:90, the flow rate is 0.5m L/min, the detection wavelength is 200nm, the column temperature is 40 ℃, and the injection volume is 5u L.
5. The method for detecting cyanoacetamide by reverse-phase high performance liquid chromatography as claimed in claim 1, wherein the mobile phase is acetonitrile-methanol-ammonium formate volatile buffer solution.
6. The method for detecting cyanoacetamide by reverse-phase high performance liquid chromatography as claimed in claim 1, which comprises the following steps:
(1) weighing a proper amount of a cyanoacetamide standard substance, and dissolving the cyanoacetamide standard substance in acetonitrile to obtain a cyanoacetamide standard substance solution;
(2) weighing a proper amount of cyanoacetamide sample, and dissolving the cyanoacetamide sample in acetonitrile to obtain a cyanoacetamide standard solution;
(3) and (3) taking the cyanoacetamide standard solution and the sample solution, injecting the cyanoacetamide standard solution and the sample solution into a high performance liquid chromatograph, and performing high performance liquid chromatography analysis according to the chromatographic conditions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010260417.7A CN111413451B (en) | 2020-04-03 | 2020-04-03 | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010260417.7A CN111413451B (en) | 2020-04-03 | 2020-04-03 | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111413451A true CN111413451A (en) | 2020-07-14 |
| CN111413451B CN111413451B (en) | 2022-05-24 |
Family
ID=71493377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010260417.7A Active CN111413451B (en) | 2020-04-03 | 2020-04-03 | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111413451B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113607837A (en) * | 2021-07-28 | 2021-11-05 | 四川汇宇制药股份有限公司 | Method for detecting cyanoacetamide and related substances thereof |
| CN114577927A (en) * | 2022-01-24 | 2022-06-03 | 河北广祥制药有限公司 | Method for detecting residual impurities in entacapone |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030129761A1 (en) * | 2001-12-27 | 2003-07-10 | Hirotaka Kakita | Method for simultaneous analysis of saccharide mixture and analytical apparatus system therefor |
| JP2009270966A (en) * | 2008-05-08 | 2009-11-19 | Denki Kagaku Kogyo Kk | Measuring method of molecular weight distribution of hyaluronic acid in biological sample of mammal origin |
| CN103926333A (en) * | 2013-01-16 | 2014-07-16 | 苏州赛分科技有限公司 | High performance liquid chromatography detection method for cyanoacetamide |
| CN110057959A (en) * | 2019-05-24 | 2019-07-26 | 山东新华制药股份有限公司 | A kind of analysis method of the high effective liquid chromatography for measuring Febustat intermediate in relation to substance |
-
2020
- 2020-04-03 CN CN202010260417.7A patent/CN111413451B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030129761A1 (en) * | 2001-12-27 | 2003-07-10 | Hirotaka Kakita | Method for simultaneous analysis of saccharide mixture and analytical apparatus system therefor |
| JP2009270966A (en) * | 2008-05-08 | 2009-11-19 | Denki Kagaku Kogyo Kk | Measuring method of molecular weight distribution of hyaluronic acid in biological sample of mammal origin |
| CN103926333A (en) * | 2013-01-16 | 2014-07-16 | 苏州赛分科技有限公司 | High performance liquid chromatography detection method for cyanoacetamide |
| CN110057959A (en) * | 2019-05-24 | 2019-07-26 | 山东新华制药股份有限公司 | A kind of analysis method of the high effective liquid chromatography for measuring Febustat intermediate in relation to substance |
Non-Patent Citations (1)
| Title |
|---|
| 徐瑾等: "液相色谱荧光衍生法在糖类物质分析中的应用", 《色谱》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113607837A (en) * | 2021-07-28 | 2021-11-05 | 四川汇宇制药股份有限公司 | Method for detecting cyanoacetamide and related substances thereof |
| CN114577927A (en) * | 2022-01-24 | 2022-06-03 | 河北广祥制药有限公司 | Method for detecting residual impurities in entacapone |
| CN114577927B (en) * | 2022-01-24 | 2023-09-01 | 河北广祥制药有限公司 | Method for detecting residual impurities in entacapone |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111413451B (en) | 2022-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roy et al. | Replacing methanol with azeotropic ethanol as the co-solvent for improved chiral separations with supercritical fluid chromatography (SFC) | |
| CN101526509B (en) | Method for rapidly determining content of preservatives in condiment | |
| CN111413451B (en) | Method for detecting cyanoacetamide by reversed-phase high performance liquid chromatography | |
| Chen et al. | Detection of organophosphorus pesticide residues in leaf lettuce and cucumber through molecularly imprinted solid-phase extraction coupled to gas chromatography | |
| Can et al. | Reversed-phase HPLC analysis of levetiracetam in tablets using monolithic and conventional C18 silica columns | |
| CN102445507B (en) | Method for determining vinyl content in methyl vinylsiloxane rubber or silicone oil | |
| CN109142586B (en) | Method for determining content of atorvastatin calcium intermediate ATS-9 and impurity B thereof by liquid chromatography | |
| CN114778743B (en) | Detection method of trace chiral isomer D-proline in L-proline | |
| CN102854279A (en) | Method for determining contents of benzene and benzene-series substances in tobacco-use triacetin | |
| CN105158348A (en) | Method for determining five effective components in zedoary oil by using gas chromatography | |
| CN110895264A (en) | Method for determining ethyl bromide in tenofovir alafenamide | |
| CN111458432B (en) | Method for detecting ethyl trifluoroacetoacetate by high performance liquid chromatography | |
| CN101532995B (en) | Method for determining antiseptic content rapidly in spice with grease | |
| CN111044640B (en) | Method for determining content of gamma-aminobutyric acid in feed additive by GC (gas chromatography) method | |
| Dolan | The role of the signal-to-noise ratio in precision and accuracy | |
| CN101846660B (en) | Determination method of trace furadan | |
| Fujimoto et al. | Metal‐element‐selective detection in packed microcolumn supercritical fluid chromatography combined with inductively coupled plasma atomic emission spectrometry | |
| CN108469477A (en) | A kind of assay method of Benzene in Beverages carbamide compound | |
| Yuan et al. | Improved analysis of sinigrin in Ethiopian mustard | |
| CN106596752B (en) | A kind of method for separating and analyzing of the cis-trans-isomer of liquid crystal intermediates hexahydrobenzaldehyde and its derivative | |
| CN104316620B (en) | A kind of detection method of trace triazine herbicide | |
| CN106404925B (en) | The method for measuring 6 kinds of barbiturates in people's whole blood | |
| KR102198842B1 (en) | Apparatus and method for generating dead time of gaschromatography | |
| Martínez Vidal et al. | Determination of acetamiprid by HPLC-fluorescence with post-column photoderivatization and HPLC-mass selective detection | |
| CN109557213B (en) | Quantitative determination of DNAN content by GC-AED irrelevant calibration curve method (CIC method) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 256500 Boxing Economic Development Zone, Shandong, Binzhou Patentee after: Shandong Jingbo Agrochemical Technology Co.,Ltd. Address before: 256500 Boxing Economic Development Zone, Shandong, Binzhou Patentee before: JINGBO AGROCHEMICALS TECHNOLOGY Co.,Ltd. |